高级搜索

HPV感染对口咽癌无病生存期影响的Meta分析

陈法, 何保昌, 黄江峰, 刘芳萍, 林李嵩, 郑晓燕, 蔡琳

陈法, 何保昌, 黄江峰, 刘芳萍, 林李嵩, 郑晓燕, 蔡琳. HPV感染对口咽癌无病生存期影响的Meta分析[J]. 肿瘤防治研究, 2016, 43(1): 30-34. DOI: 10.3971/j.issn.1000-8578.2016.01.007
引用本文: 陈法, 何保昌, 黄江峰, 刘芳萍, 林李嵩, 郑晓燕, 蔡琳. HPV感染对口咽癌无病生存期影响的Meta分析[J]. 肿瘤防治研究, 2016, 43(1): 30-34. DOI: 10.3971/j.issn.1000-8578.2016.01.007
shu
CHEN Fa, HE Baochang, HUANG Jiangfeng, LIU Fangping, LIN Lisong, ZHENG Xiaoyan, CAI Lin. Meta-analysis of Association Between HPV Infection and Disease-free Survival of Oropharyngeal Cancer Patients[J]. Cancer Research on Prevention and Treatment, 2016, 43(1): 30-34. DOI: 10.3971/j.issn.1000-8578.2016.01.007
Citation: CHEN Fa, HE Baochang, HUANG Jiangfeng, LIU Fangping, LIN Lisong, ZHENG Xiaoyan, CAI Lin. Meta-analysis of Association Between HPV Infection and Disease-free Survival of Oropharyngeal Cancer Patients[J]. Cancer Research on Prevention and Treatment, 2016, 43(1): 30-34. DOI: 10.3971/j.issn.1000-8578.2016.01.007
shu

HPV感染对口咽癌无病生存期影响的Meta分析

  • 1. 350108 福州，福建医科大学公共卫生学院流行病与卫生统计学系；2. 350004 福州， 福建医科大学附属第一医院口腔颌面外科

基金项目: 国家自然科学基金（30771845, 81172766）；头颈部肿瘤遗传因素与环境因素的国际多中心研究项目（2014B008）；福建省教育厅科研目（JA13141）
详细信息
    作者简介:

    陈法（1990-），男，博士在读，主要从事肿瘤流行病学研究

    通讯作者:

    蔡琳，E-mail: cailin_cn@hotmail.com

  • 中图分类号: R739.63

Meta-analysis of Association Between HPV Infection and Disease-free Survival of Oropharyngeal Cancer Patients

  • 1. Department of Epidemiology and Health Statistic, School of Public Health, Fujian Medical University, Fuzhou 350108, China; 2. Department of Stomatology, The First Affiliated Hospital of Fujian Medical University, Fuzhou 350004, China

摘要

    摘要
  • 摘要: 目的 综合评价人乳头状瘤病毒（HPV）感染与口咽癌无病生存期（disease-free survival,DFS）的关联。方法 检索中国知网、维普、万方、PubMed等数据库，全面收集研究HPV感染与口咽癌无病生存期关系的文献，设定纳入和排除标准，评价文献质量，检验异质性，计算合并风险比（HR）及其95%可信区间（95%CI），评估发表偏倚。结果 纳入文献16篇，口咽癌病例共2 512例，其中HPV阳性1 210例，HPV阳性率48.17%，HPV阴性1 302例。与HPV阴性相比，HPV感染的口咽癌病例复发或转移风险较低（合并HR: 0.371, 95%CI: 0.231~0.511），其中HPV-16型感染对口咽癌DFS的合并HR为0.248, 95%CI: 0.132~0.365；HPV阳性且p16蛋白表达对口咽癌DFS有保护作用（合并HR:0.281, 95%CI: 0.137~0.424)。结论 HPV感染对口咽癌无病生存期可能有保护作用。

     

    Abstract: Objective To evaluate the relationship between HPV infection and the disease-free survival (DFS) of oropharyngeal cancer (OPC) patients. Methods Databases including CNKI, VIP, Wanfang data and PubMed were searched for relevant studies on HPV infection and OPC prognosis. According to the inclusion and exclusion criteria, these studies were screened, and the merging relative risk ratio (HR) and 95% confidence interval (95%CI) were calculated. Results A total of 16 qualified articles were involved, including 2 512 OPC patients (1 210 cases of HPV positive and 1 302 cases of HPV negative). HPV positive rate was 48.17%. Compared with HPV negative patients, HPV infection had a protective effect on the recurrence or metastasis of OPC (HR: 0.371, 95%CI: 0.231-0.511); the single type of HPV-16 infection had lower risk of DFS of OPC (HR: 0.248, 95%CI: 0.132-0.365). Simultaneous HPV16 positive and p16 overexpression was inversely related with the low risk of recurrence or metastasis of OPC (HR: 0.281, 95%CI: 0.137-0.424). Conclusion HPV infection may be a beneficial factor for the DFS of oropharyngeal cancer patients.

     

    • HTML全文
    • 参考文献(31)
  • [1] Warnakulasuriya S. Global epidemiology of oral and oropharyngeal cancer[J]. Oral Oncol, 2009, 45(4-5): 309-16.
    [2] Cleveland JL, Junger ML, Saraiya M, et al. The connection between human papillomavirus and oropharyngeal squamous cell carcinomas in the United States: implications for dentistry[J]. J Am Dent Assoc, 2011, 142(8): 915-24.
    [3] Dalianis T. Human papillomavirus and oropharyngeal cancer, the epidemics, and significance of additional clinical biomarkers for prediction of response to therapy[J]. Int J Oncol, 2014, 44(6):1799-805.
    [4] Nichols AC, Faquin WC, Westra WH, et al. HPV-16 infection predicts treatment outcome in oropharyngeal squamous cell carcinoma[J]. Otolaryngol Head Neck Surg, 2009, 140(2): 228-34.
    [5] Shi W, Kato H, Perez-Ordonez B, et al. Comparative prognostic value of HPV16 E6 mRNA compared with in situ hybridization for human oropharyngeal squamous carcinoma[J]. J Clin Oncol, 20 09, 27(36): 6213-21.
    [6] Weinberger PM, Yu Z, Haffty BG, et al. Molecular classification identifies a subset of human papillomavirus-associated oropharyngeal cancers with favorable prognosis[J]. J Clin Oncol, 20 06, 24(5): 736-47.
    [7] Hayden J A, Côté P, Bombardier C. Evaluation of the quality of prognosis studies in systematic reviews[J]. Ann Intern Med, 2006, 14 4(6): 427-37.
    [8] McShane LM, Altman DG, Sauerbrei W, et al. Reporting recommendations for tumor marker prognostic studies (REMARK)[J]. J Natl Cancer Inst, 2005, 97(16): 1180-4.
    [9] Reimers N, Kasper HU, Weissenborn SJ, et al. Combined analysis of HPV-DNA, p16 and EGFR expression to predict prognosis in oropharyngeal cancer[J]. Int J Cancer, 2007, 120(8):1731-8.
    [10] Preuss SF, Weinell A, Molitor M, et al. Nuclear survivin expression is associated with HPV-independent carcinogenesis and is an indicator of poor prognosis in oropharyngeal cancer[J]. Br J Cancer, 2008, 98(3): 627-32.
    [11] Nichols AC, Finkelstein DM, Faquin WC, et al. Bcl2 and human papilloma virus 16 as predictors of outcome following concurrent chemoradiation for advanced oropharyngeal cancer[J]. Clin Cancer Res, 2010, 16(7): 2138-46.
    [12] Ukpo OC, Flanagan JJ, Ma XJ, et al. High-risk human papillomavirus E6/E7 mRNA detection by a novel in situ hybridization assay strongly correlates with p16 expression and patient outcomes in oropharyngeal squamous cell carcinoma[J]. Am J Surg Pathol, 2011, 35(9): 1343-50.
    [13] Attner P, Du J, Näsman A, et al. Human papillomavirus and survival in patients with base of tongue cancer[J]. Int J Cancer, 20 11, 128(12): 2892-7.
    [14] Hong A, Jones D, Chatfield M, et al. HPV status of oropharyngeal cancer by combination HPV DNA/p16 testing: biological relevance of discordant results[J]. Ann Surg Oncol, 2013, 20 Supp l3: S450-8.
    [15] Lee LA, Huang CG, Liao CT, et al. Human papillomavirus-16 infection in advanced oral cavity cancer patients is related to an increased risk of distant metastases and poor survival [J]. PLoS One, 2012, 7(7): e40767.
    [16] Cheng NM, Chang JT, Huang CG, et al. Prognostic value of pretreatment 18F-FDG PET/CT and human papillomavirus type 16 testing in locally advanced oropharyngeal squamous cell carcinoma[J]. Eur J Nucl Med Mol Imaging, 2012, 39(11): 1673-84.
    [17] Duray A, Descamps G, Decaestecker C, et al. Human papillomavirus DNA strongly correlates with a poorer prognosis in oral cavity carcinoma[J]. Laryngoscope, 2012, 122(7): 1558-65.
    [18] Reuschenbach M, Kansy K, Garbe K, et al. Lack of evidence of human papillomavirus induced squamous cell carcinomas of the oral cavity in southern Germany[J]. Oral Oncol, 2013, 49(9): 93 7-42.
    [19] Nichols AC, Dhaliwal SS, Palma DA, et al. Does HPV type affect outcome in oropharyngeal cancer[J]. J Otolaryngol Head Neck Surg, 2013, 42: 9.
    [20] Tural D, Eliçin O, Batur S, et al. Human papillomavirus is independent prognostic factor on outcome of oropharyngeal squamous cell carcinoma [J]. Tumor Biol, 2013, 34(6): 3363-9.
    [21] Wakisaka N, Yoshida S, Kondo S, et al. HPV Status Determines the Efficacy of Adjuvant Chemotherapy With S-1, an Oral Fluorouracil Prodrug, in Oropharyngeal Cancer[J]. Ann Otol Rhinol Laryngol, 2015, 124(5): 400-6.
    [22] Li LC, Wang ST, Sun JH. Progress of study on metastasis and recurrence-related gene molecule of the tongue carcinoma[J]. Zhongguo Lin Chuang Xin Yi Xue, 2013, 6(5): 505-8. [李丽楚, 王舒婷, 孙晋虎. 舌癌转移复发相关基因分子的研究进展[J]. 中 国临床新医学, 2013, 6(5): 505-8.]
    [23] Ragin CC, Taioli E. Survival of squamous cell carcinoma of the head and neck in relation to human papillomavirus infection: review and meta-analysis[J]. Int J Cancer, 2007, 121(8): 1813-20.
    [24] Vu HL, Sikora AG, Fu S, et al. HPV-induced oropharyngeal cancer, immune response and response to therapy[J]. Cancer Lett, 20 10, 288(2): 149-55.
    [25] Ang KK, Harris J, Wheeler R, et al. Human papillomavirus and survival of patients with oropharyngeal cancer[J]. N Engl J Med, 20 10, 363(1): 24-35.
    [26] Kansky AA, Poljak M, Seme K, et al. Human papillomavirus DNA in oral squamous cell carcinomas and normal oral mucosa[J]. Acta Virol, 2003, 47(1): 11-6.
    [27] Senzaki H, Osaki T, Uemura Y, et al. Adenoid basal carcinoma of the uterine cervix: immunohistochemical study and literature review[J]. Jpn J Clin Oncol, 1997, 27(6): 437-41.
    [28] Li XQ, Xu TX, Wang JB, et al. Utility of in situ PCR and in situ hybridization for detecting cervical cancer and precancerous lesions of HPV DNA[J]. Lin Chuang Yu Shi Yan Bing Li Xue Za Zhi, 2001, 17(1): 87-8. [李西启, 徐廷香, 王剑波, 等. 应用原 位PCR和原位杂交技术检测宫颈癌及癌前病变组织中HPV DNA[J]. 临床与实验病理学杂志, 2001, 17(1): 87-8.]
    [29] Krupar R, Hartl M, Wirsching K, et al. Comparison of HPV prevalence in HNSCC patients with regard to regional and socioeconomic factors[J]. Eur Arch Otorhinolaryngol, 2014, 271(6): 17 37-45.
    [30] Khode S R, Dwivedi RC, Rhys-Evans P, et al. Exploring the link between human papilloma virus and oral and oropharyngeal cancers[J]. J Cancer Res Ther, 2014, 10(3): 492-8.
    [31] Sasaki T, Moles DR, Imai Y, et al. Clinico-pathological features of squamous cell carcinoma of the oral cavity in patients <40 years of age[J]. J Oral Pathol Med, 2005, 34(3): 129-33.
    • 相关文章
    • 施引文献
    • 资源附件(0)
计量
  • 文章访问数:  1120
  • HTML全文浏览量:  307
  • PDF下载量:  664
  • 被引次数: 0
出版历程
  • 收稿日期:  2015-01-28
  • 修回日期:  2015-03-18
  • 刊出日期:  2016-01-24

目录

摘要
HTML全文
    参考文献(31)
    相关文章
    施引文献
    资源附件(0)

    /

    返回文章
    返回

    下载中心

    友情链接

    联系我们

    地址：武汉市洪山区卓刀泉南路116号（430079）

    电话：027－87670126

    Email：zlfzyjzz@vip.163.com

    This work is licensed under a Creative Commons Attribution 3.0 License.

    邮件订阅 RSS
    总访问量：11627569 今日访问：35329

    版权所有 © 《肿瘤防治研究》编辑部 鄂公网安备 42011102005013号 鄂ICP备2022015867号

    本系统由北京仁和汇智信息技术有限公司开发  百度统计

    x 关闭 永久关闭